Evofem Biosciences Inc. buy DomRuinart
Start price
21.02.22
/
50%
€6.20
Target price
21.02.23
€13.50
Performance (%)
2.90%
End price
07.03.22
€6.38
Summary
This prediction ended on 07.03.22 with a price of €6.38. The BUY prediction by DomRuinart finished with a performance of 2.90%. DomRuinart has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Evofem Biosciences Inc. | - | - | - |
iShares Core DAX® | 2.821% | -1.953% | 15.071% |
iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% |
iShares Nikkei 225® | 3.687% | -4.221% | 14.286% |
iShares S&P 500 | 3.577% | -2.240% | 25.546% |
According to DomRuinart what are the pros and cons of Evofem Biosciences Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by DomRuinart for this prediction
In the thread Evofem Biosciences diskutieren
Buy mit Kursziel 0,0
Kursziel geändert auf 0,9
In the thread Trading Evofem Biosciences
Buy beendet
Stopped prediction by DomRuinart for Evofem Biosciences Inc.
Evofem Biosciences Inc.
Start price
Target price
Perf. (%)
€6.08
17.02.22
17.02.22
€12.00
17.02.23
17.02.23
2.02%
21.02.22
21.02.22
Could be very worthwhile Investment >20% year